StockGumshoe: Vaccine Proven in clinical trials to eliminate lethal forms of cancer with a single dose One small company owns the patent to this life-saving treatment Its $6 shares are projected to surge 2,700% on an imminent FDA announcement Hello, my name is Joe Duarte, M.D.
I’ve spent the last 25 years practicing medicine. And during all that time, I’ve seen more than my fair share of ridiculous headlines about “ground-breaking” medical therapies.
But what I’m about to tell you is something entirely different. This is the real deal.
There’s a lot of excitement in the medical community about one of the most game-changing discoveries—ever.
A Nobel Prize-winning breakthrough proven to cure mankind’s worst disease… sometimes with just a single dose.
I call them “Alpha Cells.”
And while I doubt that 1 in 1,000 Americans has ever heard of them…
Cancer centers across America are buzzing with the results of this life-saving therapy.
Leaders in the medical community can barely contain their enthusiasm.
Like Edgar Engelman, M.D., Ph.D., a professor of pathology and medicine at Stanford, whose groundbreaking research shows, “We could use [Alpha Cells] to eliminate any kind of cancer.”
Or Harmon Eyre, Vice President of Research at the American Medical Association, whose lengthy studies on Alpha Cells have revealed, “Patients’ responses are far out of proportion to anything that any current cancer therapy could do.”
And then there’s Neil Martin, M.D., Ph.D., Chair of Neurosurgery at UCLA, who reveals in a new study that “[Alpha Cells] offer the best hope for a cure.”
Over 1,065 clinical studies confirm its cancer-killing potential.
Many of them are “gold-standard” trials from places like Duke… Stanford… and UCLA.
The story behind the pioneering use of “Alpha Cells” as a cancer therapy is a remarkable one…
A Stunning Discovery
Dr. Ralph Steinman, a Rockefeller University scientist, spent his entire career looking for the cure for cancer.
But his search became considerably more personal when he went for a checkup with his own doctor in 2007…
An MRI identified a kiwi-sized mass on his pancreas—and the cancer was already spreading to his lymph nodes.
The diagnosis?
Stage 4 pancreatic cancer. He had just months to live.
Dr. Steinman was already famous in the medical community for his cancer-killing discovery of our immune system’s “Alpha Cells.”
But now his life’s work left the laboratory for a real-life battle against cancer—his own.
He didn’t have time for new drug development or FDA clinical trials.
And he knew chemo and radiation were non-options.
So he contacted a small company—one he had helped found—to quickly put together an “Alpha Cells” treatment. His treatment was specifically personalized for his cancer.
His own treatment became a living testimony to the power of “Alpha Cells”…
Months passed…
Then years…
In 2011, Dr. Steinman won the Nobel Prize for his “Alpha Cells” discovery…
But just three days before the ceremony, he sadly passed away.
His treatment had enabled him to live for more than four years beyond expectations, effectively prolonging his survival rate 13 times over…
All without side effects.
During that time, he was able to continue his groundbreaking work and research… research that has helped save so many lives.
Research that won the Nobel Prize—the only one EVER awarded posthumously.
And his legacy lives on.
Less than a year later, the FDA granted the small company behind his “Alpha Cells” therapy a rare legal designation…
One that’s moved it quickly through clinical trials to phase 3…
Announcing: The Coming “Vaccine” for Cancer
The final phase of clinical trials is rapidly coming to a close.
And the results have been absolutely breathtaking.
So far they’ve shown “Alpha Cells” can…
Eliminate ALL kinds of cancer—everything from breast to lung to pancreatic Extend the life of stage 4 patients with just “months to live” to 10 years or even permanent remission All without dangerous side effects, radiation or chemo
The Secret Behind This Nobel Prize-Winning Cancer Breakthrough
“Alpha Cell” therapies are promising real hope for the war on cancer.
Unlike chemo or radiation, they harness your body’s immune system to identify and kill tumors—without harming healthy cells.
Back when I was finishing my medical residency in the early ‘80s, ideas like this were all just theory.
Now it’s not just a reality—it’s already saving lives.
“Alpha Cells” have been known as the “conductor of the immune system orchestra.”
Or the “general of the immune system army.”
Think of cancer as a powerful enemy within the gates. And whereas most new cancer therapies send out a platoon or squad against it—and lose—“Alpha Cells” instead command our body’s entire armed defenses.
That includes killer T-Cells, B-Cells, macrophages—pretty much every anti-cancer cell in our body.
Immune fighters that are lying dormant because the cancer cells have either evaded or deactivated them.
Only “Alpha Cells” are able to rally them to attack—eliminating cancer throughout the body.
That’s what makes this approach so unique. And why this cellular discovery of “Alpha Cells” won the Nobel Prize.
The problem is, our bodies don’t make enough “Alpha Cells” to mount a significant immune response against cancer.
So our immune system sits idle, like an army without a leader, as cancer cells wreak havoc on our bodies.
“Alpha Cells” change all of that.
Scientists put them back into action using this new therapy.
First, scientists isolate “Alpha Cells” and train them to identify and target cancer cells.
Then they marshal our T-Cell and B-Cell immune fighters against the cancer.
But it gets even better…
Here’s why so many patients are experiencing complete remission after an “Alpha Cells” treatment.
It Doesn’t Just Destroy Cancer Cells… It Makes Sure They Never Return
You see, “Alpha Cells” reprogram our immune system for a foolproof adaptive response to future cancer threats.
What does this mean?
Imagine your home is invaded by a burglar, but you’re able to scare him off.
Then you buy a security system for your home, so you’re better prepared the next time. That’s an adaptive response.
Your immune system also learns from its encounters with invaders—and then prepares for the next round.
It does this by “remembering” how to distinguish an invader from a harmless cell. That way it can pick the invader out in a crowd and head right for it.
Duke researchers compare “Alpha Cells” to “most wanted” posters for the immune system, since they tell the killer T-cells exactly which antigens to go after.
Think again of the invader in your home. Imagine you were able to get his picture. Or maybe you already had a security system that captured his image on video. You circulate his picture to your neighbors, so next time he’s seen in the neighborhood, he’s reported immediately. He never even gets near your house.
Now that’s a really adaptive response!
And that’s why so many patients have not just defeated cancer, but gone into complete, long-term remission…
Living lives cancer-free for years, even decades.
Thanks to “Alpha Cells.”
Hundreds of Clinical Trials Prove “Alpha Cells” Can Even Cure Stage 4 Cancer Patients
Clinical trials by some of America’s biggest scientific institutions have confirmed with hard evidence just how powerful this breakthrough is.
Stanford University led the charge with studies right when “Alpha Cells” were first discovered.
The thirty-one lymphoma patients who took part in the 20-year study are still alive today.
The Wall Street Journal called the results a “seismic shift in cancer research.”
Recently, Duke University researchers used “Alpha Cells” to target the ultra-lethal brain cancer—a glioblastoma. (The same cancer Bryan had.)
And the results were incredible…
Remember, these patients have only months to live.
But over half of the patients treated in the Duke study survived for 5 years or longer.
Just imagine. If this therapy can defeat the most lethal, untreatable form of brain cancer, what could it do for other kinds of cancer?
Stanford Professor: “We Could Eliminate Any Cancer”
That’s what a Stanford University research team set out to discover.
Led by Edgar Engelman, M.D., a professor of pathology and medicine at Stanford, they used “Alpha Cells” to destroy six completely different types of cancer.
That includes lung, breast, and pancreatic tumors—you name it.
According to Dr. Engelman, “The potency is impressive. You actually see tumor eradication… Pretty much we could eliminate any cancer.”
The same results are showing up again and again.
Results that are shocking researchers every single time.
It doesn’t matter what type of cancer… how advanced it is… or what treatments the patient has tried before.
“Alpha Cells” can triple or quadruple patient survival time, even give them complete remission.
It’s promising to transform more lives than anything else in development—certainly more than chemo and radiation.
The leaders in science aren’t waiting around.
They’re saving patients’ lives NOW.
“Alpha Cells” Therapy Already Approved in Germany and England
Take Germany, for instance.
Just last year their version of the FDA quickly approved an “Alpha Cells” therapy using a loophole called “Hospital Exemption.”
This is a German version of “fast-track” status, because it too allows urgent life-saving treatments to move fast through the conventional review process, getting them quickly to market.
Now it’s being used in hospitals throughout Germany to treat patients and save lives.
England followed Germany’s lead.
They accelerated this drug quickly using a new loophole called PIM (Promising Innovative Medicine).
PIM allows patients early access to vital treatments, especially those with rare diseases and few alternatives.
This critical review exception recently passed through Parliament.
And get this…
A therapy based on “Alpha Cells” was the very first to ever receive this PIM status.
Now British patients can access this life-saving therapy right away. No waiting for years of clinical trials when there is little chance they’ll be alive to see it.
Now, all of my research shows one simple fact…
Here in the United States, the FDA is about to follow suit.
When it does, thousands of dying patients will get an extended lease on life.
And investors who buy in early will get rich, while helping save the lives of people written off as “incurable.”
Something that guarantees this company billions of sales following approval…
Something that will launch this company to the heights of biotech giants…
Making it the world’s dominant “Alpha Cells” medical therapy provider.
Because for those lucky 200 people who are the first to respond to this offer, my publisher is allowing them the chance to join for only $39.95.